Ascendis Pharma A (ASND) Shares Outstanding (2012 - 2026)

Ascendis Pharma A has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $265.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 341.95% year-over-year to $265.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $265.3 million (up 341.95% YoY) and the FY2025 annual result came in at $60.6 million, up 4.69% from the prior year.
• Shares Outstanding (Entity) grew to $265.3 million in Q1 2026 per ASND's latest filing, from $60.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $265.3 million in Q1 2026 and troughed at $55.8 million in Q2 2022.
• A 5-year average of $69.8 million and a median of $56.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) decreased 1.11% in 2023, then jumped 341.95% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $56.1 million in 2022, then grew by 0.38% to $56.3 million in 2023, then climbed by 2.85% to $57.9 million in 2024, then grew by 4.69% to $60.6 million in 2025, then soared by 337.66% to $265.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $265.3 million, $60.6 million, and $60.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.